Major advances in AMD address urgent, unmet need among patients Ophthalmology Times, 09 Jun 2022 Reviewed by Jeffrey Heier, MD New 18-month data from the phase 3 DERBY and OAKS trials showed that pegcetacoplan (Empaveli…